Table 5.
Changesain serum phosphorus and SO dosage from baseline to Week 52, according to quartiles (Q) of baseline ferritinb
| Parameter | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| Serum phosphorus,b mg/dL | ||||
| Weeks −2 to 0 | 5.51 ± 0.94 | 5.55 ± 0.94 | 5.42 ± 0.93 | 5.36 ± 0.84 |
| Weeks 1–8 | 5.05 ± 0.83 | 5.09 ± 0.84 | 5.24 ± 0.72 | 5.20 ± 0.80 |
| Weeks 10–28 | 4.87 ± 0.70 | 4.92 ± 0.57 | 5.01 ± 0.67 | 5.02 ± 0.68 |
| Weeks 30–52 | 5.09 ± 0.68 | 4.97 ± 0.67 | 5.16 ± 0.78 | 5.08 ± 0.78 |
| Sucroferric oxyhydroxide dosage,b mg/day | ||||
| Weeks −2 to 0 | – | – | – | – |
| Weeks 1–8 | 940.5 ± 335.0 | 1058.5 ± 331.2 | 1022.2 ± 341.8 | 1057.6 ± 378.2 |
| Weeks 10–28 | 994.4 ± 475.9 | 1231.5 ± 577.0 | 1277.4 ± 694.6 | 1300.8 ± 677.2 |
| Weeks 30–52 | 1045.5 ± 475.6 | 1241.9 ± 548.4 | 1332.7 ± 706.3 | 1343.8 ± 598.4 |
a
Data shown are mean ± SD.
b
Quartiles of baseline serum ferritin level (Q1–Q4).